To determine whether EBV-specific cellular immunity persists and contr
ols EBV in the palatine tonsil, we compared EBV-specific cellular immu
ne responses in the palatine tonsil and peripheral blood. In 32 EBV-se
ropositive donors, we performed in vitro growth inhibition assays of E
BV-induced B-lymphocyte transformation (regression assay). The results
showed that EBV-specific cytotoxic T lymphocytes (CTL) precursor freq
uency was higher in the palatine tonsil than in the peripheral blood.
After a first stimulation with autologous lymphoblastoid cell line (LC
L), the EBV-specific cytotoxicity of reactivated CTL was higher in the
palatine tonsil than in the peripheral blood. Furthermore EBV-specifi
c CTL lines established from the palatine tonsil had significantly hig
her EBV-specific cytotoxicity in comparison with those from the periph
eral blood. Both the EBV-specific CTLs from tonsils and peripheral blo
od were restricted by HLA class-I determinants. These data indicate th
at the palatine tonsil, which is frequently exposed to EBV, plays an i
mportant role in controlling EBV infection in the oropharynx.